Category

Medical Liability

2020 — A Year in Review

By Advocacy Agenda, Congress, Health Reform, Medical Innovation, Medical Liability, Prior AuthorizationNo Comments

While 2020 is a year that most people want to forget, the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) made significant strides in accomplishing its legislative and regulatory agenda, thus ensuring that neurosurgical patients continue to have timely access to quality care. Following are some highlights of these advocacy efforts.

Congress Prevents Steep Medicare Cuts

On Jan. 1, the Centers for Medicare & Medicaid (CMS) implemented the new CPT guidelines to report office and outpatient visits based on either medical decision making or physician time. These evaluation and management (E/M) services are valued in line with the AMA/Specialty Society RVS Update Committee (RUC) recommendations. Unfortunately, to comply with Medicare’s budget neutrality requirement, any increases must be offset by corresponding decreases, and CMS estimated that the 2021 policies would increase Medicare spending by approximately $10.6 billion. This necessitated significant cuts for many specialties, including an overall 6-7% payment cut for neurosurgery. Read More

Medicolegal Issues in Neurosurgery

By CSNS Spotlight, Guest Post, Medical LiabilityNo Comments

Virtually all neurosurgeons will have to deal with a medicolegal issue by the end of their career. Neurosurgeons have the highest annualized rate of lawsuits at >19%. Perhaps shockingly, even by age 45, approximately 88% of surgeons in high-risk subspecialties will have been involved in a lawsuit. This number elevates to >99% by age 65. The concern about professional liability lawsuits is, without a doubt, the highest profile medicolegal issue for neurosurgeons — even though many more issues other than litigation affect our daily medical practices. Medicolegal and socioeconomic topics such as neurosurgical workforce, contracting and employment, and payor/insurance issues such as coverage policies, reimbursement and prior authorization regularly impact each neurosurgeon’s practice in multiple ways — even if it is not immediately apparent. Read More

A Year in review: Making Progress on Neurosurgery’s Legislative and Regulatory Agenda

By Advocacy Agenda, Congress, Health Reform, Medical Innovation, Medical Liability, Prior Authorization, UncategorizedNo Comments

As we come to the end of a decade and head into 2020, it is fitting to reflect on the progress that the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) have made in advancing organized neurosurgery’s legislative and regulatory agenda to ensure that neurosurgical patients have timely access to quality care. At the beginning of 2019, we set forth an ambitious agenda, and throughout the year, the AANS and CNS continued to make progress on achieving our health policy goals.

Read More

AANS and CNS Release 2017 Legislative and Regulatory Agenda

By Access to Care, Antitrust, Coding and Reimbursement, Congress, Drugs and Devices, Emergency Care, GME, Health, Health Reform, Healthcare Costs, HIT, IPAB, MACRA, MedEd, Medical Innovation, Medical Liability, Medicare, Quality ImprovementNo Comments

On February 14, 2017 the AANS and CNS released their 2017 legislative and regulatory agenda, which includes action items such as improving the health care delivery system, abolishing the Independent…

Read More